Rosuvastatin D3 Sodium

• CAT Number: I001107
• CAS Number: 1279031-70-7
• Molecular Formula: C22H24D3FN3NaO6S
• Molecular Weight: 506.54
• Purity: ≥95%
• Target: Autophagy
• Solubility: 10 mM inDMSO
• Storage: 3 years -20C powder
• IUPAC Name: sodium;(E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methylsulfonyl(trideuteriomethyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate
• InChI: InChI=1S/C22H28FN3O6S.Na/c1-13(2)20-18(10-9-16(27)11-17(28)12-19(29)30)21(14-5-7-15(23)8-6-14)25-22(24-20)26(3)33(4,31)32;/h5-10,13,16-17,27-28H,11-12H2,1-4H3,(H,29,30);/q;+1/p-1/b10-9+;/t16-,17-;/m1./s1/i3D3
• InChIKey: RGEBGDYYHAFODH-SYRJKFITSA-M
• SMILES: CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C.[Na+]

Rosuvastatin D3 Sodium（Cat No.:I001107） is a deuterated version of Rosuvastatin Sodium, where three hydrogen atoms are replaced with deuterium. This isotopic modification enhances the compound’s stability and is crucial for detailed pharmacokinetic and metabolic studies of Rosuvastatin, a widely used statin for lowering cholesterol. The deuterated form allows for precise measurement and analysis of the drug’s behavior in the body, improving the accuracy of studies on drug absorption, distribution, and elimination. It is particularly valuable in developing and validating analytical methods, ensuring consistent and reliable results in clinical research and pharmaceutical development.